Patents by Inventor Riccardo MANCUSO

Riccardo MANCUSO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SMALL MOLECULE LFA-1 INHIBITORS
    Publication number: 20190040008
    Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.
    Type: Application
    Filed: August 2, 2018
    Publication date: February 7, 2019
    Applicant: ALLOCYTE PHARMACEUTICALS AG
    Inventors: Werner BREITENSTEIN, Marianne HUERZELER, Terence KELLY, Riccardo MANCUSO, Gisbert SCHNEIDER, Gabriele WEITZ-SCHMIDT
  • Small molecule LFA-1 inhibitors
    Patent number: 10077238
    Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: September 18, 2018
    Assignee: ALLOCYTE PHARMACEUTICALS AG
    Inventors: Werner Breitenstein, Marianne Huerzeler, Terence Kelly, Riccardo Mancuso, Gisbert Schneider, Gabriele Weitz-Schmidt
  • SMALL MOLECULE LFA-1 INHIBITORS
    Publication number: 20170121284
    Abstract: The present invention relates to novel compounds which are capable of inhibiting the interaction of LFA-1 with its counter ligands.
    Type: Application
    Filed: June 10, 2015
    Publication date: May 4, 2017
    Applicant: ALLOCYTE PHARMACEUTICALS AG
    Inventors: Werner BREITENSTEIN, Marianne HUERZELER, Terence KELLY, Riccardo MANCUSO, Gisbert SCHNEIDER, Gabriele WEITZ-SCHMIDT